{"id":"https://openalex.org/W2015470347","doi":"https://doi.org/10.1097/00007691-200006000-00010","title":"Rituximab (IDEC-C2B8): Validation of a Sensitive Enzyme-Linked Immunoassay Applied to a Clinical Pharmacokinetic Study","display_name":"Rituximab (IDEC-C2B8): Validation of a Sensitive Enzyme-Linked Immunoassay Applied to a Clinical Pharmacokinetic Study","publication_year":2000,"publication_date":"2000-06-01","ids":{"openalex":"https://openalex.org/W2015470347","doi":"https://doi.org/10.1097/00007691-200006000-00010","mag":"2015470347","pmid":"https://pubmed.ncbi.nlm.nih.gov/10850396"},"language":"en","primary_location":{"id":"doi:10.1097/00007691-200006000-00010","doi":"https://doi.org/10.1097/00007691-200006000-00010","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00007691-200006000-00010","pdf_url":null,"source":{"id":"https://openalex.org/S179268941","display_name":"Therapeutic Drug Monitoring","issn_l":"0163-4356","issn":["0163-4356","1536-3694"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic Drug Monitoring","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5081294616","display_name":"I Iacona","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I25217355","display_name":"University of Pavia","ror":"https://ror.org/00s6t1f81","country_code":"IT","type":"education","lineage":["https://openalex.org/I25217355"]},{"id":"https://openalex.org/I4210151645","display_name":"Policlinico San Matteo Fondazione","ror":"https://ror.org/05w1q1c88","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210151645","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Isabella Iacona","raw_affiliation_strings":["Department of Pharmacology, University of Pavia, IRCCS Policlinico San Matteo, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, University of Pavia, IRCCS Policlinico San Matteo, Italy","institution_ids":["https://openalex.org/I25217355","https://openalex.org/I4210151645"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105782864","display_name":"Mario Lazzarino","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I25217355","display_name":"University of Pavia","ror":"https://ror.org/00s6t1f81","country_code":"IT","type":"education","lineage":["https://openalex.org/I25217355"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Mario Lazzarino","raw_affiliation_strings":["University of Pavia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pavia","institution_ids":["https://openalex.org/I25217355"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074897422","display_name":"Maria Antonietta Avanzini","orcid":"https://orcid.org/0000-0002-6056-9018","observed_orcids":["https://orcid.org/0000-0002-6056-9018"]},"institutions":[{"id":"https://openalex.org/I4210151645","display_name":"Policlinico San Matteo Fondazione","ror":"https://ror.org/05w1q1c88","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210151645","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Maria Antonietta Avanzini","raw_affiliation_strings":["IRCCS Fondazione Policlinico San Matteo"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IRCCS Fondazione Policlinico San Matteo","institution_ids":["https://openalex.org/I4210151645"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089607807","display_name":"Maurizio Rupolo","orcid":"https://orcid.org/0000-0001-7932-2827","observed_orcids":["https://orcid.org/0000-0001-7932-2827"]},"institutions":[{"id":"https://openalex.org/I4210128630","display_name":"Centro di Riferimento Oncologico","ror":"https://ror.org/03ks1vk59","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210128630","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Maurizio Rupolo","raw_affiliation_strings":["Division of Medical Oncology, Centro di Riferimento Oncologico, Aviano, Italy","Centro di Riferimento Oncologico"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology, Centro di Riferimento Oncologico, Aviano, Italy","institution_ids":["https://openalex.org/I4210128630"]},{"raw_affiliation_string":"Centro di Riferimento Oncologico","institution_ids":["https://openalex.org/I4210128630"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019034145","display_name":"Luca Arcaini","orcid":"https://orcid.org/0000-0002-9504-991X","observed_orcids":["https://orcid.org/0000-0002-9504-991X"]},"institutions":[{"id":"https://openalex.org/I4210151645","display_name":"Policlinico San Matteo Fondazione","ror":"https://ror.org/05w1q1c88","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210151645","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Luca Arcaini","raw_affiliation_strings":["IRCCS Fondazione Policlinico San Matteo"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IRCCS Fondazione Policlinico San Matteo","institution_ids":["https://openalex.org/I4210151645"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113679896","display_name":"Cesare Astori","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151645","display_name":"Policlinico San Matteo Fondazione","ror":"https://ror.org/05w1q1c88","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210151645","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Cesare Astori","raw_affiliation_strings":["IRCCS Fondazione Policlinico San Matteo"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IRCCS Fondazione Policlinico San Matteo","institution_ids":["https://openalex.org/I4210151645"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033908863","display_name":"F. Lunghi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I25217355","display_name":"University of Pavia","ror":"https://ror.org/00s6t1f81","country_code":"IT","type":"education","lineage":["https://openalex.org/I25217355"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Francesca Lunghi","raw_affiliation_strings":["University of Pavia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pavia","institution_ids":["https://openalex.org/I25217355"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102777260","display_name":"Ester Maria Orlandi","orcid":"https://orcid.org/0000-0003-1588-3558","observed_orcids":["https://orcid.org/0000-0003-1588-3558"]},"institutions":[{"id":"https://openalex.org/I4210151645","display_name":"Policlinico San Matteo Fondazione","ror":"https://ror.org/05w1q1c88","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210151645","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Ester Orlandi","raw_affiliation_strings":["IRCCS Fondazione Policlinico San Matteo"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IRCCS Fondazione Policlinico San Matteo","institution_ids":["https://openalex.org/I4210151645"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111689884","display_name":"Enrica Morra","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210094195","display_name":"Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda","ror":"https://ror.org/00htrxv69","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210094195"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Enrica Morra","raw_affiliation_strings":["Division of Hematology, Niguarda Hospital, Milano, Italy","Niguarda Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Niguarda Hospital, Milano, Italy","institution_ids":["https://openalex.org/I4210094195"]},{"raw_affiliation_string":"Niguarda Hospital","institution_ids":["https://openalex.org/I4210094195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034356923","display_name":"Vittorina Zagonel","orcid":"https://orcid.org/0000-0002-0829-2525","observed_orcids":["https://orcid.org/0000-0002-0829-2525","https://orcid.org/0009-0004-2762-1998"]},"institutions":[{"id":"https://openalex.org/I4210109345","display_name":"Istituto Oncologico Veneto","ror":"https://ror.org/01xcjmy57","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210109345","https://openalex.org/I4210153126"]},{"id":"https://openalex.org/I4210128630","display_name":"Centro di Riferimento Oncologico","ror":"https://ror.org/03ks1vk59","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210128630","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Vittorina Zagonel","raw_affiliation_strings":["Division of Medical Oncology, Centro di Riferimento Oncologico, Aviano, Italy","Istituto Oncologico Veneto"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology, Centro di Riferimento Oncologico, Aviano, Italy","institution_ids":["https://openalex.org/I4210128630"]},{"raw_affiliation_string":"Istituto Oncologico Veneto","institution_ids":["https://openalex.org/I4210109345"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108501150","display_name":"Mario Bonora Regazzi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I25217355","display_name":"University of Pavia","ror":"https://ror.org/00s6t1f81","country_code":"IT","type":"education","lineage":["https://openalex.org/I25217355"]},{"id":"https://openalex.org/I4210151645","display_name":"Policlinico San Matteo Fondazione","ror":"https://ror.org/05w1q1c88","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210151645","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Mario B. Regazzi","raw_affiliation_strings":["Departments of Pharmacology, \u2020Hematology, and \u2021Pediatrics, University of Pavia, IRCCS Policlinico San Matteo, Pavia, Italy","IRCCS Fondazione Policlinico San Matteo"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Pharmacology, \u2020Hematology, and \u2021Pediatrics, University of Pavia, IRCCS Policlinico San Matteo, Pavia, Italy","institution_ids":["https://openalex.org/I25217355"]},{"raw_affiliation_string":"IRCCS Fondazione Policlinico San Matteo","institution_ids":["https://openalex.org/I4210151645"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5081294616","https://openalex.org/A5108501150"],"corresponding_institution_ids":["https://openalex.org/I25217355","https://openalex.org/I4210151645"],"apc_list":null,"apc_paid":null,"fwci":1.1309,"has_fulltext":false,"cited_by_count":66,"citation_normalized_percentile":{"value":0.75969605,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"22","issue":"3","first_page":"295","last_page":"301"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.6348000168800354,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.6348000168800354,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.3127000033855438,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.02410000003874302,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":1.0},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.722000002861023},{"id":"https://openalex.org/keywords/cd20","display_name":"CD20","score":0.6740000247955322},{"id":"https://openalex.org/keywords/follicular-lymphoma","display_name":"follicular lymphoma","score":0.7649999856948853},{"id":"https://openalex.org/keywords/non-hodgkin-lymphoma","display_name":"non-Hodgkin lymphoma","score":0.8259999752044678},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.75},{"id":"https://openalex.org/keywords/elisa-validation","display_name":"ELISA validation","score":0.7519999742507935},{"id":"https://openalex.org/keywords/serum-drug-levels","display_name":"serum drug concentration","score":0.753000020980835},{"id":"https://openalex.org/keywords/elimination-half-life","display_name":"elimination half-life","score":0.8970000147819519},{"id":"https://openalex.org/keywords/antibody-accumulation","display_name":"antibody accumulation","score":0.6819999814033508},{"id":"https://openalex.org/keywords/consolidation-chemotherapy","display_name":"consolidation chemotherapy","score":0.640999972820282},{"id":"https://openalex.org/keywords/treatment-response-prediction","display_name":"treatment response prediction","score":0.46000000834465027}],"concepts":[{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.9241714477539062},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.768856942653656},{"id":"https://openalex.org/C2777058707","wikidata":"https://www.wikidata.org/wiki/Q123251","display_name":"Follicular lymphoma","level":3,"score":0.7564127445220947},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7238315343856812},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.6425637006759644},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.5835447907447815},{"id":"https://openalex.org/C2780420688","wikidata":"https://www.wikidata.org/wiki/Q759183","display_name":"Immunoassay","level":3,"score":0.5349109768867493},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4746856391429901},{"id":"https://openalex.org/C163864487","wikidata":"https://www.wikidata.org/wiki/Q6901461","display_name":"Monoclonal","level":4,"score":0.44731104373931885},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.43935948610305786},{"id":"https://openalex.org/C18031839","wikidata":"https://www.wikidata.org/wiki/Q5009796","display_name":"CD20","level":3,"score":0.4199782609939575},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.38499772548675537},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.36742034554481506},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.32762229442596436}],"mesh":[{"descriptor_ui":"D000069283","descriptor_name":"Rituximab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001825","descriptor_name":"Body Fluid Compartments","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004355","descriptor_name":"Drug Stability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004797","descriptor_name":"Enzyme-Linked Immunosorbent Assay","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007262","descriptor_name":"Infusions, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008224","descriptor_name":"Lymphoma, Follicular","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D008224","descriptor_name":"Lymphoma, Follicular","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D008224","descriptor_name":"Lymphoma, Follicular","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011241","descriptor_name":"Prednisone","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D012680","descriptor_name":"Sensitivity and Specificity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014750","descriptor_name":"Vincristine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D015203","descriptor_name":"Reproducibility of Results","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058846","descriptor_name":"Antibodies, Monoclonal, Murine-Derived","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/00007691-200006000-00010","doi":"https://doi.org/10.1097/00007691-200006000-00010","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00007691-200006000-00010","pdf_url":null,"source":{"id":"https://openalex.org/S179268941","display_name":"Therapeutic Drug Monitoring","issn_l":"0163-4356","issn":["0163-4356","1536-3694"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic Drug Monitoring","raw_type":"journal-article"},{"id":"pmid:10850396","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10850396","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic drug monitoring","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":15,"referenced_works":["https://openalex.org/W60759546","https://openalex.org/W78060682","https://openalex.org/W206701898","https://openalex.org/W1484629663","https://openalex.org/W1524901905","https://openalex.org/W1556939483","https://openalex.org/W1915689252","https://openalex.org/W2006998103","https://openalex.org/W2040505385","https://openalex.org/W2066388140","https://openalex.org/W2096055205","https://openalex.org/W2099314298","https://openalex.org/W2106542190","https://openalex.org/W2112476236","https://openalex.org/W2168750246"],"related_works":["https://openalex.org/W2050864184","https://openalex.org/W2004454256","https://openalex.org/W2010197986","https://openalex.org/W1564461906","https://openalex.org/W2058767405","https://openalex.org/W2168750246","https://openalex.org/W4406606545","https://openalex.org/W6986328110","https://openalex.org/W2948617697","https://openalex.org/W2031395363"],"abstract_inverted_index":{"Rituximab":[0,47,99,115,140],"is":[1],"a":[2,35,61,65,107,137,155],"chimeric":[3],"monoclonal":[4],"antibody":[5],"(MAb)":[6],"directed":[7],"against":[8],"the":[9,30,54,57,81,92,97,111,124,146,166,170],"B-cell":[10],"CD20":[11],"antigen":[12],"that":[13],"has":[14],"been":[15],"approved":[16],"for":[17,123,164,173],"therapy":[18],"of":[19,34,56,68,78,84,89,118,127,158],"relapsed":[20],"and":[21,32,105,143,172],"resistant":[22],"follicular":[23,71],"non-Hodgkin's":[24],"lymphoma":[25,72],"(NHL).":[26],"This":[27,50],"study":[28,51,63],"describes":[29,53],"development":[31],"validation":[33],"highly":[36],"sensitive,":[37],"rapid,":[38],"accurate,":[39],"precise":[40,156],"enzyme-linked":[41],"immunosorbent":[42],"assay":[43],"(ELISA)":[44],"to":[45,60,169,177],"measure":[46],"serum":[48,100,130,141,159],"concentrations.":[49],"also":[52],"application":[55],"ELISA":[58,147],"method":[59,148],"pharmacokinetic":[62,134],"in":[64,94,129,150],"homogeneous":[66],"group":[67],"patients":[69,93,175],"with":[70],"who":[73],"received":[74],"4":[75],"weekly":[76],"doses":[77],"MAb":[79,128,171],"at":[80],"standard":[82],"dose":[83],"375":[85],"mg/m2":[86],"as":[87],"consolidation":[88],"chemotherapy.":[90],"In":[91],"this":[95,151],"study,":[96,152],"median":[98],"concentrations":[101],"increased":[102],"during":[103,110],"therapy,":[104],"showed":[106,136],"slow":[108],"decline":[109],"posttreatment":[112],"period.":[113],"The":[114],"elimination":[116],"half-life":[117],"approximately":[119],"20":[120],"days":[121],"accounts":[122],"demonstrated":[125],"accumulation":[126],"samples.":[131],"Because":[132],"previous":[133],"studies":[135],"correlation":[138],"between":[139],"levels":[142],"tumor":[144],"response,":[145],"used":[149],"which":[153],"allows":[154],"control":[157],"concentrations,":[160],"could":[161],"be":[162],"useful":[163],"predicting":[165],"final":[167],"response":[168],"selecting":[174],"able":[176],"benefit":[178],"from":[179],"higher":[180],"dosage":[181],"or":[182],"repeated":[183],"drug":[184],"administration.":[185]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":3},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}